Qiagen (QGEN) Research & Development (2009 - 2025)

Qiagen (QGEN) has 17 years of Research & Development data on file, last reported at $47.2 million in Q4 2025.

• Quarterly Research & Development fell 2.82% year-over-year to $47.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $187.5 million (down 3.09% YoY) and the FY2025 annual result came in at $187.5 million, down 3.09% from the prior year.
• Research & Development eased to $47.2 million in Q4 2025 per QGEN's latest filing, from $48.7 million in the prior quarter.
• The five-year high for Research & Development was $54.7 million in Q1 2023, with the low at $42.1 million in Q4 2021.
• Average Research & Development over 5 years is $48.0 million, with a median of $47.9 million recorded in 2023.
• Year-over-year, Research & Development jumped 63.9% in 2021 and slipped 14.71% in 2025.
• Qiagen's Research & Development stood at $42.1 million in 2021, then climbed by 6.19% to $44.7 million in 2022, then grew by 2.79% to $46.0 million in 2023, then gained by 5.74% to $48.6 million in 2024, then fell by 2.82% to $47.2 million in 2025.
• Business Quant data shows QGEN's Research & Development at $47.2 million in Q4 2025, $48.7 million in Q3 2025, and $47.8 million in Q2 2025.